Global Pharmaceutical Policy
Show Less

Global Pharmaceutical Policy

Ensuring Medicines for Tomorrow’s World

Frederick M. Abbott and Graham Dukes

Pharmaceuticals play a central role in health care throughout the world. The pharmaceutical industry is beset with difficulties as increasing research and development expenditure yields fewer new treatments. Public and private budgets strain under the weight of high prices and limited access. The world’s poor see little effort to address diseases prevalent in less affluent societies, while the world’s wealthy are overusing prescription drugs, risking their health and wasting resources.
Buy Book in Print
Show Summary Details
You do not have access to this content

Chapter 3: Policies on Innovation: Past, Present and Future

Frederick M. Abbott and Graham Dukes


POLICY AND INNOVATION Innovation – in the sense of the discovery or development of new and better medicines – is critical to addressing present and future public health needs. Official policies have sometimes sought to encourage or facilitate such innovation, or have done so incidentally. Governments have also been accused of discouraging innovation, especially by imposing excessive regulatory requirements, either on the process itself or on the products that emerge from it. In considering the various options for policy, it is important to consider the manner in which drug innovation comes about and the means by which it is likely to be attained in the future. ERAS OF INNOVATION Until early in the twentieth century, professional medicine was almost entirely reliant on an armory of relatively old medicines that had been in use for generations, and in some cases for centuries. The great bulk of these – such as opium as an analgesic, senna as a laxative and plant extracts containing tannin for use as astringents – were of herbal origin. As a rule, each was prepared by the local apothecary from the plants with which he was familiar. Much the same applied to the inorganic materials and substances of animal origin that were in use. Knowledge was largely passed on from one generation to the next through apprenticeship. Yet there was some formalized teaching of materia medica. And, since antiquity, a number of standard works on the subject had appeared, the oldest being that of the Greek Pedanius Discorides (AD 54–68). Over...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information

or login to access all content.